These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 278852)

  • 1. Biochemical and ultrastructural studies on estrogen-induced pituitary tumors in F344 rats.
    De Nicola AF; von Lawzewitsch I; Kaplan SE; Libertun C
    J Natl Cancer Inst; 1978 Sep; 61(3):753-63. PubMed ID: 278852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.
    Lloyd RV
    Am J Pathol; 1983 Nov; 113(2):198-206. PubMed ID: 6638150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
    Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
    Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glandular kallikrein in estrogen-induced pituitary tumors: time course of induction and correlation with prolactin.
    Hatala MA; Powers CA
    Cancer Res; 1988 Aug; 48(15):4158-62. PubMed ID: 3390808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual dimorphism in diethylstilbestrol-induced prolactin pituitary tumors in F344 rats.
    Piroli GG; Torres A; Pietranera L; Grillo CA; Ferrini MG; Lux-Lantos V; Aoki A; De Nicola AF
    Neuroendocrinology; 2000 Aug; 72(2):80-90. PubMed ID: 10971143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
    Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
    Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein and RNA synthesis in pituitary tumors from F344 rats given implants of estrogen.
    Kaplan SE; De Nicola AF
    J Natl Cancer Inst; 1976 Jan; 56(1):37-42. PubMed ID: 1255750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary.
    Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK
    Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue.
    Maeda T; Lloyd RV
    Lab Invest; 1993 Apr; 68(4):472-80. PubMed ID: 8479155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diethylstilbestrol and propylthiouracil on the rat pituitary. An immunohistochemical and ultrastructural study.
    Lloyd RV; Mailloux J
    J Natl Cancer Inst; 1987 Oct; 79(4):865-73. PubMed ID: 3477666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical structure and function in rats bearing an adrenocorticotrophic hormone, growth hormone, and prolactin-secreting tumor.
    Nickerson PA; Brownie AC; Molteni A
    Lab Invest; 1970 Oct; 23(4):368-77. PubMed ID: 4360549
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of prolactin and growth hormone production in hyperplastic and neoplastic rat pituitary tissues by the hemolytic plaque assay.
    Lloyd RV; Coleman K; Fields K; Nath V
    Cancer Res; 1987 Feb; 47(4):1087-92. PubMed ID: 3542200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of polymorphisms near the rat prolactin, N-ras, and retinoblastoma genes with susceptibility to estrogen-induced pituitary tumors.
    Shepel LA; Gorski J
    Cancer Res; 1990 Dec; 50(24):7920-5. PubMed ID: 1979252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
    Gruszka A; Kunert-Radek J; Pawlikowski M
    Neuro Endocrinol Lett; 2005 Feb; 26(1):51-4. PubMed ID: 15726020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor.
    Pandey J; Bannout A; Wendell DL
    Carcinogenesis; 2004 Oct; 25(10):1829-38. PubMed ID: 15166088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of DNA in oestrogen-induced pituitary tumurs in rats: effect of bromocriptine.
    Kalbermann LE; Machiavelli GA; De Nicola AF; Weissenberg LS; Burdman JA
    J Endocrinol; 1980 Nov; 87(2):221-4. PubMed ID: 7430920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bromocriptine on prolactin cellular hypertrophy, proliferation and secretory activity in diethylstilbestrol-induced pituitary tumors.
    Phelps CJ; Hymer WC
    Mol Cell Endocrinol; 1988 Aug; 58(2-3):137-48. PubMed ID: 3208992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological studies on estrogen-induced PRL cell hyperplasia in rat pituitary gland--immunocytochemical and scanning electron microscopic studies].
    Inagaki H; Hori T
    No To Shinkei; 1989 Jun; 41(6):593-601. PubMed ID: 2803826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
    Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.